# Sutro Biopharma, Inc.: Form 8-K, filed Jun 8, 2026

- Company: [Sutro Biopharma, Inc.](/companies/stro.md) (CIK 1382101)
- Form: 8-K
- Filed: 2026-06-08
- Accepted by EDGAR: Jun 8, 2026, 16:01 ET
- Period: 2026-06-05
- Accession: 0001193125-26-261658
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1382101/000119312526261658/d116098d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1382101/000119312526261658/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1382101/000119312526261658/d116098d8k.htm

Filed Jun 8, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-261658. Last ingested by Listed: Nov 13, 2026, 16:35 ET. No prices; not investment advice.
